2nd Circ. Affirms Biotech Founder's Win In Trading Suit
By Katryna Perera · July 14, 2025, 5:26 PM EDT
The Second Circuit on Monday affirmed an early win for the founder of biotech Y-mAbs Therapeutics Inc. in a suit alleging he realized more than $2.5 million in short-swing profits after...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login